Discover how USP27X, a deubiquitinating enzyme, is emerging as a promising drug target for lung cancer treatment through innovative research and validation experiments.
Discover how 3′-epi-12β-hydroxyfroside, a novel cardenolide, induces cytoprotective autophagy by blocking the Hsp90/Akt/mTOR axis in lung cancer cells.
Discover how UBE2C promotes lung cancer progression by stabilizing MMP9 protein, revealing new therapeutic targets for cancer treatment.
Discover how Dioscin from wild yam inhibits non-small cell lung cancer by downregulating Survivin protein and activating apoptosis pathways.
Discover how TRIM59 protein serves as a prognostic biomarker and therapeutic target in non-small cell lung cancer treatment.
Discover how a single detrimental mutation in the USP40 gene drives tumorigenesis in rare lung cancer cases through groundbreaking research.
Explore how the ubiquitin system functions as the cell's protein disposal mechanism and its emerging role as a therapeutic target in lung cancer treatment.
Discover how DHA from fish oil triggers EGFR degradation in lung cancer cells through dual degradation pathways - a breakthrough in cancer research.
Discover how RepID protein could revolutionize diagnosis and treatment of lung neuroendocrine tumors, a rare cancer with limited options.
Discover how microRNA-375 acts as a cellular traffic controller fighting lung squamous cell carcinoma through the ERK pathway regulation.